Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-10-7
pubmed:abstractText
To assess the additive effect of dorzolamide hydrochloride 2% on the diurnal intraocular pressure (IOP) curve and retrobulbar haemodynamics in patients with primary open-angle glaucoma (POAG) treated with morning-dosed bimatoprost 0.03%.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1468-2079
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1307-11
pubmed:meshHeading
pubmed-meshheading:20558428-Adult, pubmed-meshheading:20558428-Aged, pubmed-meshheading:20558428-Aged, 80 and over, pubmed-meshheading:20558428-Amides, pubmed-meshheading:20558428-Antihypertensive Agents, pubmed-meshheading:20558428-Blood Flow Velocity, pubmed-meshheading:20558428-Cloprostenol, pubmed-meshheading:20558428-Drug Synergism, pubmed-meshheading:20558428-Drug Therapy, Combination, pubmed-meshheading:20558428-Female, pubmed-meshheading:20558428-Glaucoma, Open-Angle, pubmed-meshheading:20558428-Hemodynamics, pubmed-meshheading:20558428-Humans, pubmed-meshheading:20558428-Intraocular Pressure, pubmed-meshheading:20558428-Male, pubmed-meshheading:20558428-Middle Aged, pubmed-meshheading:20558428-Ophthalmic Artery, pubmed-meshheading:20558428-Ophthalmic Solutions, pubmed-meshheading:20558428-Orbit, pubmed-meshheading:20558428-Prospective Studies, pubmed-meshheading:20558428-Single-Blind Method, pubmed-meshheading:20558428-Sulfonamides, pubmed-meshheading:20558428-Thiophenes
pubmed:year
2010
pubmed:articleTitle
The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma.
pubmed:affiliation
Department of Ophthalmology, Military Health Service Institute, 128 Szaserów Str., Warsaw 44, Poland.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't